by Patricia Logullo, Esther J. van Zuuren, Christopher C. Winchester, David Tovey, William T. Gattrell, Amy Price, Niall Harrison, Keith Goldman, Alison Chisholm, Kirsty Walters, Paul Blazey Background When research evidence is limited, inconsistent, or absent, healthcare decisions and policies need to be based on consensus among interested stakeholders....

by Ahmed M. Arzika, Amza Abdou, Ramatou Maliki, Nassirou Beido, Boubacar Kadri, Abdoul N. Harouna, Abdoul N. Galo, Mankara K. Alio, Elodie Lebas, Catherine E. Oldenburg, Kieran S. O’Brien, Cindi Chen, Lina Zhong, Zhaoxia Zhou, Daisy Yan, Armin Hinterwirth, Jeremy D. Keenan, Travis C. Porco, Thomas M. Lietman, Thuy Doan, for the MORDOR Study Group ...

by Lyndon P. James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi, Dumitru Chesov, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Ted Cohen, Nicolas A. Menzies Background Emerging evidence suggests that shortened, simplified treatment regimens for rifampicin-resistant tuberculosis (RR-TB) can achieve comparable...

by Binh Nguyen, Philip Clare, Gregore I. Mielke, Wendy J. Brown, Ding Ding Background There is little long-term causal evidence on the effect of physical activity on health-related quality of life. This study aimed to examine the associations between longitudinal patterns of physical activity over 15 years and health-related quality of life in both...

by Yi Sun, Rashmi Bhuyan, Anqi Jiao, Chantal C. Avila, Vicki Y. Chiu, Jeff M. Slezak, David A. Sacks, John Molitor, Tarik Benmarhnia, Jiu-Chiuan Chen, Darios Getahun, Jun Wu Background Epidemiological findings regarding the association of particulate matter ≤2.5 μm (PM2.5) exposure with hypertensive disorders in pregnancy (HDP) are inconsistent; evidence...

by Robin Feldman In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.